Merck's consistent dividend payments over 34 years, healthy balance sheet, and attractive valuation highlight its investment ...

But by the end of the decade, the company should be on its way to replacing Keytruda as its now sold with a new formulation of the medicine. And Merck's business extends beyond this single product.

Are you a print subscriber? Activate your account. By Garett Sloane - 2 hours 35 min ago By Gillian Follett - 2 hours 35 min ago By E.J. Schultz - 2 hours 35 min ago By Jack Neff - 2 hours 35 min ...

Merck MRK announced that the U.S. Centers for ... completed their vaccine series with both PCV13 and PPSV23. These new ...

Germany-based tech company Merck has opened a new spin-on-dielectric (SOD) application centre in Anseong, South Korea. It has invested $10m (€9m) to construct the new lab. SOD is a material ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the European Commission (EC) has approved two new indications for KEYTRUDA ® (pembrolizumab), Merck ...

RAHWAY, N.J. (AP) — RAHWAY, N.J. (AP) — Merck & Co. (MRK) on Thursday reported third-quarter profit of $3.16 billion. On a per-share basis, the Rahway, New Jersey-based company said it had ...

Merck (MRK) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.

Oct 17 (Reuters) - German science and technology group Merck (MRCG.DE), opens new tab is open to more acquisitions for its Life Science business after announcing in May it would buy Mirus Bio for ...

Merck KGaA said it’s seeing the beginning of a post-Covid pandemic rebound in life sciences as it reaffirmed the group’s sales and profit guidance for the full year. The German science and ...